3rd Quarter - Report

TODD STRATEGY GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Presidents Budget Fiscal Year 2027. Government funding policy issues.

LobbyistCovered position, as disclosed
ERIC BERGREN —
KATHERINE FLEMING COTTON —
PAUL EDATTEL —
NICOLAS MAGALLANES —
DANIEL M TODD —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Biopharmaceutical innovation policy issues. Biosimilar approval and reimbursement policy issues.

LobbyistCovered position, as disclosed
ERIC BERGREN —
KATHERINE FLEMING COTTON —
PAUL EDATTEL —
NICOLAS MAGALLANES —
DANIEL M TODD —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Pharmacy PHA

User fee issues. Vaccine policy issues. Pharmacy Benefit Manager reform and policy issues. Drug cost and pricing policy issues. Most Favored Nation (MFN) policy issues. Drug importation policy issues. FDA policy issues. Competition policy issues. Orphan Drug Act policy issues. Antimicrobial resistance policy issues. Supply chain policy issues. 340B drug discount program rebate and policy issues. Drug shortages policy issues . Executive Order 14297: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients. Executive Order 14273: Lowering Drug Prices by Once Again Putting Americans First. Biopharmaceutical innovation policy issues. Pricing and reimbursement policy issues. Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues.

LobbyistCovered position, as disclosed
ERIC BERGREN Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
KATHERINE FLEMING COTTON Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
PAUL EDATTEL Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
NICOLAS MAGALLANES Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Health Issues HCR

Patient assistance program policy issues.

LobbyistCovered position, as disclosed
ERIC BERGREN —
KATHERINE FLEMING COTTON —
PAUL EDATTEL —
NICOLAS MAGALLANES —
DANIEL M TODD —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

H.R.1: One Big Beautiful Bill Act (Public Law 119-21). Part D redesign and policy issues including non-interference and rebates policy issues. Part B policy issues. Drug cost and pricing policy issues. Medicare rebate policy issues. Center for Medicare and Medicaid Innovation (CMMI) policy issues. CMS IPAY Guidance on the Medicare Drug Price Negotiation Program. IPAY and Maximum Fair Prices policy issues. Medicaid rebate policy issues. GENErating cost Reductions for U.S. Medicaid (GENEROUS) model. Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule. Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule. IRA price negotiation expansion policy issues.

LobbyistCovered position, as disclosed
ERIC BERGREN —
KATHERINE FLEMING COTTON —
PAUL EDATTEL —
NICOLAS MAGALLANES —
DANIEL M TODD —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1 (119th)

Trade (domestic/foreign) TRD

Tariff policy issues.

LobbyistCovered position, as disclosed
ERIC BERGREN —
KATHERINE FLEMING COTTON —
PAUL EDATTEL —
NICOLAS MAGALLANES —
DANIEL M TODD —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.